KRT8 and prostate cancer: The preponderance of NE and non-NE prostate cancer at end stage varied among individual mice, but some TKO-Nicd1 mice had non-NE adenocarcinoma (KRT8+SYP–INSM1–) as the predominant end-stage tumor.